Tirzepatide for the treatment of adults with type 2 diabetes: An endocrine perspective

Tirzepatide is a novel glucose‐dependent insulinotropic polypeptide/glucagon‐like peptide 1 (GLP‐1) receptor agonist approved in the United States as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes and under investigation for use in chronic weight manageme...

Descripción completa

Detalles Bibliográficos
Autores principales: De Block, Christophe, Bailey, Clifford, Wysham, Carol, Hemmingway, Andrea, Allen, Sheryl Elaine, Peleshok, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2022
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087310/
https://www.ncbi.nlm.nih.gov/pubmed/35929488
http://dx.doi.org/10.1111/dom.14831

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087310/
https://www.ncbi.nlm.nih.gov/pubmed/35929488
http://dx.doi.org/10.1111/dom.14831

Ejemplares similares